Answer
Yes, hand-foot syndrome (palmar-plantar erythrodysaesthesia) was among the most common adverse reactions of any grade with Sutent (sunitinib malate) in RCC, GIST and pNET registrational trials, and symptoms may diminish as treatment continues.
Sources for this answer
- SUTENT 50mg Hard CapsulesPfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 52Document updated
Sources checked